4//SEC Filing
MOCH KENNETH I 4
Accession 0001062993-23-013667
CIK 0001621443other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:30 PM ET
Size
8.6 KB
Accession
0001062993-23-013667
Insider Transaction Report
Form 4
MOCH KENNETH I
Director
Transactions
- Award
Common Stock
2023-06-13+47,824→ 75,893 total - Sale
Common Stock
2023-06-14$0.35/sh−115$40→ 75,778 total - Award
Stock Option (right to buy)
2023-06-13+71,736→ 71,736 totalExercise: $0.35Exp: 2033-06-13→ Common Stock (71,736 underlying)
Footnotes (3)
- [F1]The restricted stock award vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders.
- [F2]This transaction represents shares required to be sold by the Reporting Person to satisfy certain equity plan administrator fees and taxes in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.
- [F3]The option vests in full upon the earlier of (i) June 13, 2024 or (ii) the day before the Company's 2024 annual meeting of stockholders.
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001070009
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:30 PM ET
- Size
- 8.6 KB